Global Alliance for Tb Drug Development (Tb Alliance)
Tuberculosis non-profit drug development company
Based in NY
🤖
AI Overview
With $700K in lobbying spend across 33 quarterly filings, Global Alliance for Tb Drug Development (Tb Alliance) is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
$700K
Total Spend
8
Years Active
1
Firms Hired
5
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $120K |
| 2020 | $100K |
| 2021 | $80K |
| 2022 | $80K |
| 2023 | $80K |
| 2024 | $80K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Foreign Relations, Budget/Appropriations
- •Annual appropriations for Labor, Health & Human Services, Department of Defense, and State and Foreign Operations bills
- •Report language and funding for TB programs at USAID, HHS and DoD
- •US role in TB research and development
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.